BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 29574651)

  • 1. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma.
    Watanabe A; Araki K; Hirai K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Hoshino K; Kuwano H; Shirabe K
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):886-891. PubMed ID: 27444106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases.
    Wang DS; Yang H; Liu XY; Chen ZG; Wang Y; Fong WP; Hu MT; Zheng YC; Zheng Y; Li BK; Yuan YF; Chen G; Pan ZZ; Song L; Li YH; Xu RH
    Theranostics; 2021; 11(14):7018-7028. PubMed ID: 34093868
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis.
    Sasaki Y; Hokuto D; Inoue T; Nomi T; Yoshikawa T; Matsuo Y; Koyama F; Sho M
    Ann Surg Oncol; 2019 Nov; 26(12):3982-3989. PubMed ID: 31313042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.
    de Ridder JA; Knijn N; Wiering B; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S638-45. PubMed ID: 25986865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma.
    Cao J; Fu Z; Gao L; Wang X; Cheng S; Wang X; Ren H
    World J Surg Oncol; 2017 Feb; 15(1):48. PubMed ID: 28219450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
    Pikoulis E; Margonis GA; Andreatos N; Sasaki K; Angelou A; Polychronidis G; Pikouli A; Riza E; Pawlik TM; Antoniou E
    Anticancer Res; 2016 Sep; 36(9):4805-11. PubMed ID: 27630332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
    Cai HX; Li XQ; Wang SF
    World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients.
    Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto M; Ohdan H
    Int J Surg; 2016 Dec; 36(Pt A):96-103. PubMed ID: 27741421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative blood loss independently predicts survival and recurrence after resection of colorectal cancer liver metastasis.
    Jiang W; Fang YJ; Wu XJ; Wang FL; Lu ZH; Zhang RX; Ding PR; Fan WH; Pan ZZ; De-Sen Wan
    PLoS One; 2013; 8(10):e76125. PubMed ID: 24098431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
    Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
    Li X; Shu K; Zhou J; Yu Q; Cui S; Liu J; Zhou R; Ding D
    Clin Genitourin Cancer; 2020 Feb; 18(1):11-19.e1. PubMed ID: 31787543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum D-dimer as a prognostic marker in patients undergoing radiofrequency ablation of colorectal liver metastasis.
    Tellioglu G; Agcaoglu O; Siperstein A; Berber E
    J Invest Surg; 2012 Oct; 25(5):295-300. PubMed ID: 23020269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases.
    Liu M; Bao Q; Zhao T; Huang L; Zhang D; Wang Y; Yan X; Wang H; Jin K; Liu W; Wang K; Xing B
    Hepatol Int; 2024 Jun; 18(3):1029-1039. PubMed ID: 38427145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
    Watanabe A; Harimoto N; Araki K; Yoshizumi T; Arima K; Yamashita Y; Baba H; Tetsuya H; Kuwano H; Shirabe K
    J Surg Oncol; 2018 Dec; 118(7):1088-1095. PubMed ID: 30261101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.